Due to the growing number of reports indicating the significant role of individual Wnt pathway components in cancer pathogenesis, the assessment of Wnt5a expression in prostate adenocarcinoma and BPH may be of great importance in guiding new therapies directly targeting the regulation of Wnt pathway activity. This evidence concerns the gene WNT5A and cancer.